LabCorp https://www.LabCorp.com launched the LabCorp AT Home COVID-19 Test Collection Service, which is the first seamless digital service aimed at helping doctors test patients for COVID-19 before surgeries and other important treatments.
Doctors now can directly order a LabCorp At Home COVID-19 test for their patient through a digital interface with LabCorp. Once the order is placed, LabCorp will send the COVID-19 kit to the patient who will then perform the sample collection using a nasal swab and send it back to LabCorp via FedEx.
When the results are available, LabCorp will deliver the patient’s test results to the provider’s EMR and the patient’s LabCorp Patient Portal, which can make the process seamless. The doctor than has the information to make the appropriate clinical decision prior to proceeding with surgery or other treatments.
LabCorp is piloting the service with select providers initially and plans to make the service available to more health systems, hospitals, and surgical centers through the providers’ EMRs in coming weeks.
The home collection kit has not been FDA cleared or approved but was authorized by the FDA under an Emergency Use Authorization (EUA). The kit has been authorized only for home collection and maintenance of nasal swab specimens as an aid to detect nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
Go to https://www.labcorp.com/labcorp-home-kit-provider-information for more information on the home test.